Parallel Advisors, LLC - PARATEK PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,658
+65.8%
750
+141.9%
0.00%
Q2 2019$1,000
-93.8%
310
-89.9%
0.00%
-100.0%
Q1 2019$16,000
+45.5%
3,061
+41.6%
0.00%0.0%
Q4 2018$11,000
-38.9%
2,161
+16.1%
0.00%0.0%
Q3 2018$18,000
+157.1%
1,861
+165.9%
0.00%
+100.0%
Q2 2018$7,0007000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders